AzTrials
AzTrials

Healthy VolunteerNCT02321995

A Quantitative Optical Sensor to Monitor Vascular Physiology; A Healthy Volunteer Study

An observational study of Healthy Volunteer, run by Zenalux Biomedical, Inc. at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aims to evaluate the Zenalux IM1, an optical spectroscopy device with a pressure sensor. The pressure sensor is intended to overcome the inconsistencies attributable to variations in use of the device. This study will involve using the device on healthy volunteers. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Healthy Volunteer
How many people
10 participants
Where
1 siteUnited States
Study dates
Jun 2016to Oct 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Healthy Volunteers

Who may be able to join

  • Healthy volunteer with no presentation of disease (such as no complaints or self-reported oral symptoms or lesions; no cold or flu like symptoms) that would affect the reflective measurements in the oral cavity
  • Age 18 or older
  • Subjects of all ethnic and gender groups will be included
  • Ability to understand and the willingness to sign a written informed consent document

Who cannot join

  • Subjects considered in "vulnerable" populations such as children under the age of 18
  • Complaint of oral symptoms or lesions
  • Current cold or flu like symptoms (self-reported)
  • Pregnancy (self-reported by menstrual history)

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Duke University Medical Center

    Durham, North Carolina, 27705

Other trials in United States

About this study

This study aims to evaluate the Zenalux IM1, an optical spectroscopy device with a pressure sensor. The pressure sensor is intended to overcome the inconsistencies attributable to variations in use of the device. This study will involve using the device on healthy volunteers. Three tissue parameters will be used to analyze the pressure effects in two ways: within- and across-subject variability. Measurements will be taken under the tongue and on the inside of the cheek. The device is noninvasive and is approved for preclinical use.

Read the detailed description

PURPOSE OF THE STUDY:

  1. There exist significant systematic and random errors in the in vivo spectroscopic measurement of tissue hemoglobin concentrations, blood oxygenation, and scattering coefficient due to uncontrolled probe-to-tissue interface and the lack of a real-time calibration.
  2. It is possible to design and engineer a fiber optic sensor to perform accurate and reproducible diffuse reflectance spectroscopy (DRS) for noninvasive quantification of tissue physiology and morphology in vivo. Features such as probe pressure control and instrument self-calibration will improve signal-to-noise ratios by removing user bias from optical measurements.

STUDY OBJECTIVES

  1. Evaluation of the pressure sensor in healthy volunteers to determine the minimum contact pressure required for spectroscopic measurements

DESIGN AND PROCEDURES:

Evaluation of the pressure sensor in a volunteer study (n=10)

Informed consent will be obtained from all volunteers. In order to assess the pressure sensor, all research procedures will be repeated twice (once with the aid of the stepper motor and once without the aid of the stepper motor.) For the first five subjects, measurements will be made with the stepper motor first followed by measurements without the stepper motor. The remaining five-subjects will receive the measurements in the reverse order (no stepper motor following by stepper motor). Before the optical measurements, all subjects will be asked to rinse their mouth with a 0.9% saline solution in order to minimize the influence of consumed food. The instrument is high-level disinfected prior to each use in cidex or sterilized by ethylene oxide per standard clinical procedure. Furthermore, it is not anticipated that this device will pose a significant risk to vulnerable populations. The probe will be covered with an optically clear protective sterile sheath and placed in contact with the soft tissue. Reflectance measurements will be taken from each volunteer at up to 5 pressure levels (25, 50, 75, 100, 150 mmHg). At each pressure level 10 spectra will be acquired sequentially. The first measurement will start immediately after the desired probe pressure is reached. This will generate a total of 100 sample and calibration spectra pairs from each subject. This will be repeated on other sites including the tongue, cheek and gums. The sample spectrum will be calibrated using the calibration spectrum collected concurrently. Three tissue parameters will be used to analyze the pressure effects which is described here with [THb] as an example: First, the mean [THb] and its standard deviation will be calculated from the 10 repeat measurements at each pressure for each subject for measurements with and without the stepper motor and plotted against the probe pressure (refer to as THb-P curve). Second, at each pressure level, the [THb] will be plotted against time for each subject and the curve will indicate the temporal response of the tissue under that probe pressure. A series of paired t-tests will be used to identify the contact pressure at which minimal [THb] variance occurs over time (when stepper motor is used). Next, the variance at that contact pressure will be compared to the case without the stepper motor to demonstrate a significant reduction in pressure variance.

The investigators do not anticipate any risks to participants, however, there are a few potential minimal risks such as loss of confidentiality; slight risk of infection; discomfort at the pressure sites; and jaw discomfort as a result of the mouth being opened for several minutes.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. minimum contact pressure required for spectroscopic measurements

    Measured: at the time the optical measurements are collected

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Dec 2014 (estimated)
  2. Study startJun 2016
  3. Primary completionOct 2016
  4. Study completionOct 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
10 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02321995
Sponsor's protocol ID
Pro00057177
Status last verified
Jun 2017
First submitted
17 Dec 2014
Last updated
2 Jul 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Healthy Volunteer, run by Zenalux Biomedical, Inc. at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jul 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

minimum contact pressure required for spectroscopic measurements (time frame: at the time the optical measurements are collected). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in